Epioxa obtained FDA approval in October 2025, which makes it the first and only FDA-approved epithelium-on, oxygen-enriched corneal cross-linking treatment for patients with keratoconus. Epioxa ...
SEATTLE — Keeping our vision strong is important throughout life. Conditions like keratoconus, though, can cause vision to decline. “The cornea is important to be clear,” said Dr. Luke Barker of ...
Credit: Glaukos. The topical drug therapy uses epithelium-on cross-linking to reduce corneal steepness in adults. Unlike traditional cross-linking procedures, this treatment does not require removal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results